WALL, N.J., May 31, 2012 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (OTCBB:BKYI), a global leader in fingerprint biometric identification solutions and advanced mobile identification technology, today reported that the company has announced the launch of its twenty seventh integration of TruStaffTM fingerprint biometric log-in for secure access to Medflow Electronic Health Records. The partnership with Medflow expands the BIO-key footprint in the healthcare industry. BIO-key technology is implemented within leading hospitals, blood centers, transfusion facilities and now eye care practices.
To date, BIO-key and Medflow have deployed solutions for Canton Ophthalmology, East Michigan Eye Center, Charles Retina Institute, Eye Centers of Texas, Nashua Eye Center, Ophthalmology Consultants of Ft. Worth, Providence Eye Center, Southwestern PA Eye Center, American Optical, Central Plaines Eye Center, Delaware Eye Center, Del Negro & Senft Eye Center, Florida Eye Center, Inland Eye Specialists, University Ophthalmology and others.
"As we all know CMS and HIPAA require strong password identification, which has a significant impact on a clinic's busy workflow. The BIO-key solution eliminates that overhead and makes it simple to identify yourself. Our clients love how easy it is to switch from one user to the other using BIO-key," said Jim Riggi, President and CEO Medflow, Inc.
Medflow is installed in over 450 practices nationwide and is being used by 2,000 plus eye care physicians daily to record over 70,000 patient visits a day. Medflow's training process is designed to get users proficient within days, and as a result the company has the highest rate of successful implementation in the industry. Its users were the first to receive payments for Meaningful Use, further testament to the deep understanding of the inner workings within eye care practices.
"The opportunity to partner with an industry leader in the eye care space was very appealing to us. The eye care category represents well over a million dollar opportunity for our company," said Mike DePasquale, Chief Executive Officer, BIO-key. "Adding a biometric element to Medflow provided the next layer of convenience and security. It also aligns with BIO-key's goal of becoming the leading biometric technology provider in healthcare as our technology is currently deployed in hundreds of hospitals, clinics and leading blood centers," added DePasquale.
About BIO-key
BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. BIO-key's award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world's largest identification deployments to improve security, guarantee identity, and help reduce identity theft. BIO-key's technology is offered directly or by market leading partners around the world. (http://www.bio-key.com)
BIO-key Safe Harbor Statement
Certain statements contained in this press release may be construed as "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, our ability to attract and retain key personnel. For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2011 and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company also undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.